- Home
- CGC vs CATX Comparison
CGC vs CATX Comparison
Compare CGC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- CATX
- Stock Information
- Founded
- CGC 2009
- CATX 1983
- Country
- CGC Canada
- CATX United States
- Employees
- CGC N/A
- CATX N/A
- Industry
- CGC Pharmaceuticals and Biotechnology
- CATX Medical/Dental Instruments
- Sector
- CGC Health Care
- CATX Health Care
- Exchange
- CGC Nasdaq
- CATX Nasdaq
- Market Cap
- CGC 174.9M
- CATX 182.9M
- IPO Year
- CGC N/A
- CATX N/A
- Fundamental
- Price
- CGC $1.32
- CATX $2.57
- Analyst Decision
- CGC Sell
- CATX Strong Buy
- Analyst Count
- CGC 2
- CATX 9
- Target Price
- CGC $2.00
- CATX $12.63
- AVG Volume (30 Days)
- CGC 7.4M
- CATX 749.8K
- Earning Date
- CGC 05-30-2025
- CATX 05-12-2025
- Dividend Yield
- CGC N/A
- CATX N/A
- EPS Growth
- CGC N/A
- CATX N/A
- EPS
- CGC N/A
- CATX N/A
- Revenue
- CGC $187,146,485.00
- CATX $1,471,000.00
- Revenue This Year
- CGC N/A
- CATX N/A
- Revenue Next Year
- CGC $7.13
- CATX N/A
- P/E Ratio
- CGC N/A
- CATX N/A
- Revenue Growth
- CGC N/A
- CATX N/A
- 52 Week Low
- CGC $0.77
- CATX $1.60
- 52 Week High
- CGC $10.04
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- CGC 43.13
- CATX 53.32
- Support Level
- CGC $1.64
- CATX $2.34
- Resistance Level
- CGC $1.99
- CATX $2.94
- Average True Range (ATR)
- CGC 0.16
- CATX 0.28
- MACD
- CGC -0.02
- CATX 0.00
- Stochastic Oscillator
- CGC 2.90
- CATX 55.95
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.